Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NRO.PA Stock Summary
Top 10 Correlated ETFs
NRO.PA
In the News
NRO.PA Financial details
Company Rating
Neutral
Market Cap
1.1B
Income
98.3M
Revenue
1.41B
Book val./share
-
Cash/share
-
Dividend
1.1
Dividend %
2.58%
Employees
6.54K
Optionable
No
Shortable
Yes
Earnings
06 Mar 2024
P/E
46.81
Forward P/E
18.17
PEG
4.2
P/S
3.06
P/B
3.14
P/C
-
P/FCF
23.11
Quick Ratio
1.25
Current Ratio
2.43
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
3.87
EPS next Y
2.52
EPS next Q
-
EPS this Y
10.93%
EPS next Y
-34.88%
EPS next 5Y
-34.5%
EPS last 5Y
9.83%
Revenue last 5Y
7.76%
Revenue Q/Q
1.04%
EPS Q/Q
-5.71%
-
-
-
-
SMA20
-
SMA50
4.65%
SMA100
28.57%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
9%
ROC
0.09%
Gross Margin
47%
Oper. Margin
11%
Profit Margin
7%
Payout
-
Shs Outstand
24.28M
Shs Float
8.3M
-
-
-
-
Target Price
-
52W Range
33.45-46.85
52W High
-0.43%
52W Low
+38.79%
RSI
55
Rel Volume
0.56
Avg Volume
8.87K
Volume
4.97K
Perf Week
4.69%
Perf Month
4.09%
Perf Quarter
26.69%
Perf Half Y
29.75%
-
-
-
-
Beta
0.513
-
-
Volatility
0.57%, 0.68%
Prev Close
0.99%
Price
45.8
Change
0.66%
NRO.PA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 21.01 | 21.64 | 23.95 | 27.47 | 25.68 | |
Net income per share | 1.27 | 1.28 | 1.56 | 1.83 | 2.03 | |
Operating cash flow per share | 2.53 | 2.85 | 2.67 | 2.27 | 0 | |
Free cash flow per share | 2.21 | 2.55 | 2.4 | 1.83 | 0 | |
Cash per share | 9 | 11 | 10.95 | 11.23 | 0 | |
Book value per share | 12.24 | 13.31 | 12.87 | 13.67 | 0 | |
Tangible book value per share | 10.18 | 11.27 | 10.85 | 11.76 | 0 | |
Share holders equity per share | 12.24 | 13.31 | 12.87 | 13.67 | 0 | |
Interest debt per share | 0.34 | 0.34 | 0.36 | 0.41 | 0 | |
Market cap | 500.21M | 567.2M | 920.2M | 950.75M | 1.26B | |
Enterprise value | 433.62M | 457.89M | 859.95M | 910.14M | 1.26B | |
P/E ratio | 16.24 | 18.35 | 24.4 | 21.49 | 21.55 | |
Price to sales ratio | 0.98 | 1.08 | 1.59 | 1.43 | 1.7 | |
POCF ratio | 8.14 | 8.22 | 14.23 | 17.31 | 0 | |
PFCF ratio | 9.34 | 9.18 | 15.84 | 21.45 | 0 | |
P/B Ratio | 1.68 | 1.76 | 2.95 | 2.87 | 0 | |
PTB ratio | 1.68 | 1.76 | 2.95 | 2.87 | 0 | |
EV to sales | 0.85 | 0.87 | 1.48 | 1.37 | 1.7 | |
Enterprise value over EBITDA | 6.82 | 6.93 | 11.42 | 10.54 | 1.7 | |
EV to operating cash flow | 7.06 | 6.64 | 13.29 | 16.57 | 0 | |
EV to free cash flow | 8.1 | 7.41 | 14.8 | 20.53 | 0 | |
Earnings yield | 0.06 | 0.05 | 0.04 | 0.05 | 0.05 | |
Free cash flow yield | 0.11 | 0.11 | 0.06 | 0.05 | 0 | |
Debt to equity | 0.02 | 0.02 | 0.02 | 0.02 | 0 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Net debt to EBITDA | -1.05 | -1.65 | -0.8 | -0.47 | 0 | |
Current ratio | 2.64 | 2.78 | 2.51 | 2.45 | 0 | |
Interest coverage | 40.01 | 50.04 | 62.6 | 41.14 | 0 | |
Income quality | 1.99 | 2.23 | 1.72 | 1.24 | 0 | |
Dividend Yield | 0 | 0.01 | 0.05 | 0.03 | 0 | |
Payout ratio | 0.05 | 0.16 | 1.28 | 0.55 | 0 | |
Sales general and administrative to revenue | 0.28 | 0.29 | 0.29 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.16 | 0.16 | 0.16 | 0.15 | 0 | |
Capex to operating cash flow | -0.13 | -0.1 | -0.1 | -0.19 | 0 | |
Capex to revenue | -0.02 | -0.01 | -0.01 | -0.02 | 0 | |
Capex to depreciation | -0.52 | -0.48 | -0.44 | -0.69 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0 | |
Graham number | 18.69 | 19.54 | 21.23 | 23.7 | 0 | |
ROIC | 0.1 | 0.09 | 0.12 | 0.14 | 0 | |
Return on tangible assets | 0.07 | 0.07 | 0.08 | 0.08 | 0 | |
Graham Net | 7.2 | 8.55 | 7.95 | 8.23 | 0 | |
Working capital | 256.38M | 287.64M | 279.57M | 299.47M | 0 | |
Tangible asset value | 247.08M | 273.28M | 262.65M | 284.98M | 0 | |
Net current asset value | 230M | 258.24M | 249.23M | 265.41M | 0 | |
Invested capital | 0.02 | 0.02 | 0.02 | 0.02 | 0 | |
Average receivables | 177.58M | 179.73M | 181.48M | 206.27M | 111.97M | |
Average payables | 31.15M | 31.85M | 35.19M | 40.33M | 21.46M | |
Average inventory | 446K | 960.5K | 1.42M | 1.26M | 494.5K | |
Days sales outstanding | 132.46 | 121.34 | 118.71 | 122.85 | 0 | |
Days payables outstanding | 24.99 | 26.15 | 26.99 | 26.84 | 0 | |
Days of inventory on hand | 0.49 | 1.05 | 1.09 | 0.62 | 0 | |
Receivables turnover | 2.76 | 3.01 | 3.07 | 2.97 | 0 | |
Payables turnover | 14.61 | 13.96 | 13.52 | 13.6 | 0 | |
Inventory turnover | 738.39 | 348.8 | 333.65 | 590.24 | 0 | |
ROE | 0.1 | 0.1 | 0.12 | 0.13 | 0 | |
Capex per share | -0.32 | -0.3 | -0.27 | -0.44 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 11.99 | 13.5 | 13.96 | 15.22 | 12.9 | |
Net income per share | 0.8 | 0.91 | 0.92 | 1.05 | 0.99 | |
Operating cash flow per share | 1.78 | 0.17 | 2.1 | 1.12 | 0 | |
Free cash flow per share | 1.66 | -0.03 | 1.86 | 0.87 | 0 | |
Cash per share | 10.94 | 9.6 | 11.23 | 10.81 | 0 | |
Book value per share | 12.86 | 12.78 | 13.67 | 13.65 | 0 | |
Tangible book value per share | 10.84 | 10.67 | 11.77 | 11.86 | 0 | |
Share holders equity per share | 12.86 | 12.78 | 13.67 | 13.65 | 0 | |
Interest debt per share | 0.34 | 0.36 | 0.37 | 0.38 | 0 | |
Market cap | 920.67M | 862.38M | 950.71M | 966.56M | 1.26B | |
Enterprise value | 860.42M | 829.96M | 910.1M | 936.79M | 1.26B | |
P/E ratio | 11.86 | 9.78 | 10.71 | 9.51 | 11.02 | |
Price to sales ratio | 3.17 | 2.64 | 2.81 | 2.62 | 3.39 | |
POCF ratio | 21.4 | 211.37 | 18.69 | 35.71 | 0 | |
PFCF ratio | 22.88 | -1.28K | 21.12 | 45.8 | 0 | |
P/B Ratio | 2.96 | 2.78 | 2.87 | 2.92 | 0 | |
PTB ratio | 2.96 | 2.78 | 2.87 | 2.92 | 0 | |
EV to sales | 2.96 | 2.54 | 2.69 | 2.54 | 3.39 | |
Enterprise value over EBITDA | 22.24 | 19.14 | 21.19 | 20.75 | 3.39 | |
EV to operating cash flow | 20 | 203.42 | 17.89 | 34.61 | 0 | |
EV to free cash flow | 21.39 | -1.23K | 20.22 | 44.39 | 0 | |
Earnings yield | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 | |
Free cash flow yield | 0.04 | 0 | 0.05 | 0.02 | 0 | |
Debt to equity | 0.02 | 0.02 | 0.02 | 0.03 | 0 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Net debt to EBITDA | -1.56 | -0.75 | -0.95 | -0.66 | 0 | |
Current ratio | 2.51 | 2.43 | 2.45 | 2.43 | 0 | |
Interest coverage | 59.37 | 37.38 | 45.88 | 59.17 | 0 | |
Income quality | 2.22 | 0.19 | 2.29 | 1.06 | 0 | |
Dividend Yield | 0 | 0.03 | 0 | 0.03 | 0 | |
Payout ratio | 0 | 1.1 | 0 | 1.05 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.16 | 0.16 | 0.15 | 0.15 | 0 | |
Capex to operating cash flow | -0.06 | -1.17 | -0.12 | -0.22 | 0 | |
Capex to revenue | -0.01 | -0.01 | -0.02 | -0.02 | 0 | |
Capex to depreciation | -0.34 | -0.64 | -0.74 | -0.79 | 0 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Graham number | 15.22 | 16.18 | 16.79 | 17.96 | 0 | |
ROIC | 0.06 | 0.07 | 0.07 | 0.07 | 0 | |
Return on tangible assets | 0.04 | 0.05 | 0.04 | 0.05 | 0 | |
Graham Net | 7.94 | 7.28 | 8.23 | 7.94 | 0 | |
Working capital | 279.57M | 272.72M | 299.47M | 298.42M | 0 | |
Tangible asset value | 262.65M | 258.59M | 284.98M | 287.29M | 0 | |
Net current asset value | 249.23M | 242.05M | 265.41M | 263.02M | 0 | |
Invested capital | 0.02 | 0.02 | 0.02 | 0.03 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 58.41 | 60.01 | 59.59 | 56.54 | 0 | |
Days payables outstanding | 13.26 | 12.38 | 12.98 | 12.89 | 0 | |
Days of inventory on hand | 0.54 | 0.76 | 0.3 | 0.73 | 0 | |
Receivables turnover | 1.54 | 1.5 | 1.51 | 1.59 | 0 | |
Payables turnover | 6.79 | 7.27 | 6.94 | 6.98 | 0 | |
Inventory turnover | 167.44 | 118.54 | 301.03 | 123.16 | 0 | |
ROE | 0.06 | 0.07 | 0.07 | 0.08 | 0 | |
Capex per share | -0.11 | -0.2 | -0.24 | -0.25 | 0 |
NRO.PA Frequently Asked Questions
What is Neurones S.A. stock symbol ?
Neurones S.A. is a FR stock and trading under the symbol NRO.PA
What is Neurones S.A. stock quote today ?
Neurones S.A. stock price is $45.8 today.
Is Neurones S.A. stock public?
Yes, Neurones S.A. is a publicly traded company.